Endo International Profile

7.63
USD 0.06  0.79%
5.93Last Month High 7.63 
7.48Trading Day  High 7.79 

Acquisition by Mchugh Julie of 26776 shares of Endo International subject to Rule 16b-3

Endo International plc insider trading alert for grant of 2010 stock incentive plan stock options by Mchugh Julie, Chief Operating Officer, on November 18, 2017. This event was filed by Endo International Plc with SEC on 2013-03-01. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Endo International Summary

Endo International plc (ENDP) is traded on NASDAQ in USA. It is located in IRELAND and employs 6,406 people. Endo International is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 1.62 B. Endo International plc conducts business under Healthcare sector and is part of Drug Manufacturers - Other industry. This company has 223.31 M outstanding shares of which 19.99 M shares are currently shorted by private and institutional investors with about 5.39 trading days to cover. ENDO PHARM HLDGS currently holds about 616.53 M in cash with 306.81 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.76.
Check Endo International Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Endo International plc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Endo International Against Markets

Current Ratings  

Endo International 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
5 
Chance of
< 46% 
Endo International plc develops, manufactures, and distributes pharmaceutical solutions and devices worldwide. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameEndo International plc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock Stocks Directory
LocationIRELAND
Business AddressDublin,
ExchangeNASDAQ
ISINUS29264F2056
CUSIPG30401106
SectorHealthcare
IndustryDrug Manufacturers - Other
BenchmarkDOW
Websitewww.endo.com
Contact Number353 1 268 2000
CurrencyUSD - US Dollar

Recommendations

Endo International Analyst Recommendations
Target PriceAdvice# of Analysts
19.36Hold14Odds
Endo International plc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Endo International Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Endo International Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.63February 28, 2017
Endo International plc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate